Advances in cell type-specific targeting and single-cell analyses will be pivotal in deciphering spatiotemporal NF-κB dynamics, enabling precision interventions tailored to tumor stage, subtype, and microenvironmental cues. The gene discussed is NFKB1; the disease is neoplasm.